Differences in Factors Linked to Heart Failure Between Men and Women
Discover how heart failure risk factors differ between men and women, emphasizing the importance of personalized medical approaches for better outcomes.
Recent research has shed light on the varying factors associated with heart failure in men and women, emphasizing the importance of sex-specific risk profiles. According to a study published on August 22, 2025, in the Journal of Primary Care and Community Health, women with heart failure with preserved ejection fraction (HFpEF) tend to be older and have higher rates of conditions such as asthma, osteoarthritis, depression, hypothyroidism, and anxiety compared to men with similar heart failure types. The study analyzed 460 women and 258 men with HFpEF and found that the likelihood of developing HFpEF increased with age, higher body mass index (BMI), and the presence of rheumatological or mental health disorders among women.
In the case of heart failure with reduced ejection fraction (HFrEF), the study included 225 women and 250 men. It revealed that women with HFrEF had higher prevalence rates of asthma, depression, hypothyroidism, and anxiety. Notably, Black women showed a greater odds ratio for HFrEF, indicating a significant racial disparity. The researchers noted that women with heart failure often present with different comorbidities compared to men, suggesting a need for tailored treatment approaches.
Overall, this study highlights that certain health conditions and demographic factors influence heart failure risk differently in men and women. Recognizing these sex-specific differences is crucial for improving prevention, diagnosis, and management strategies for heart failure.
Source: https://medicalxpress.com/news/2025-08-variables-heart-failure-men-women.html
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
Elon Musk's Neuralink Implant Restores Movement in Paralyzed Veteran During Clinical Trial
A paralyzed veteran receives Neuralink's brain chip in a pioneering clinical trial, restoring movement and control over electronic devices, marking a major breakthrough in neurotechnology.
Gut Microbiota as a Non-Invasive, Cost-Effective Screening Approach for Colorectal Cancer
New research explores how analyzing gut bacteria can serve as a non-invasive, low-cost method for early detection of colorectal cancer, potentially transforming screening practices.
Global Challenges in Women's Heart Disease Research Due to Underrepresentation in Clinical Trials
Women remain underrepresented in cardiovascular clinical trials, hindering progress in understanding and treating heart disease in women. A recent consensus highlights the need for greater inclusion to improve health outcomes.